American Well (AMWL) to Announce Earnings on Tuesday

American Well (NYSE:AMWL) is expected to be announcing its Q2 2026 results after the market closes on Tuesday, August 4th. Analysts expect American Well to post earnings of ($0.60) per share and revenue of $49.8780 million for the quarter. Individuals are encouraged to explore the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Tuesday, August 4, 2026 at 5:00 PM ET.

American Well (NYSE:AMWL) last announced its quarterly earnings results on Tuesday, May 5th. The company reported ($0.66) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.77) by $0.11. The company had revenue of $54.88 million for the quarter, compared to the consensus estimate of $51.54 million. American Well had a negative return on equity of 32.11% and a negative net margin of 37.02%. On average, analysts expect American Well to post $-3 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

American Well Price Performance

AMWL opened at $10.77 on Friday. American Well has a one year low of $3.71 and a one year high of $13.45. The business has a 50 day simple moving average of $9.60 and a two-hundred day simple moving average of $7.06. The firm has a market capitalization of $178.19 million, a price-to-earnings ratio of -1.99 and a beta of 1.69.

Insider Buying and Selling at American Well

In other news, insider Dmitry Zamansky sold 8,460 shares of the firm’s stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $9.33, for a total value of $78,931.80. Following the completion of the transaction, the insider owned 232,620 shares in the company, valued at $2,170,344.60. This trade represents a 3.51% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Stephen J. Schlegel sold 9,750 shares of the firm’s stock in a transaction that occurred on Thursday, June 11th. The shares were sold at an average price of $8.76, for a total value of $85,410.00. Following the completion of the transaction, the director owned 54,553 shares of the company’s stock, valued at approximately $477,884.28. The trade was a 15.16% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 29,225 shares of company stock valued at $268,623. 12.84% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On American Well

A number of institutional investors have recently added to or reduced their stakes in AMWL. Goldman Sachs Group Inc. lifted its position in American Well by 55.4% during the fourth quarter. Goldman Sachs Group Inc. now owns 64,110 shares of the company’s stock valued at $315,000 after buying an additional 22,845 shares during the period. Two Sigma Investments LP grew its position in shares of American Well by 22.6% in the 3rd quarter. Two Sigma Investments LP now owns 46,329 shares of the company’s stock worth $285,000 after buying an additional 8,553 shares during the period. State Street Corp grew its position in shares of American Well by 7.8% in the 4th quarter. State Street Corp now owns 52,299 shares of the company’s stock worth $257,000 after buying an additional 3,800 shares during the period. Norges Bank purchased a new stake in shares of American Well in the 2nd quarter worth about $250,000. Finally, Hsbc Holdings PLC increased its stake in shares of American Well by 186.6% in the 4th quarter. Hsbc Holdings PLC now owns 46,565 shares of the company’s stock worth $224,000 after acquiring an additional 30,316 shares in the last quarter. Institutional investors own 56.05% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on AMWL shares. TD Cowen boosted their target price on American Well from $5.00 to $8.00 and gave the company a “hold” rating in a research note on Wednesday, May 6th. Morgan Stanley raised their price target on American Well from $6.00 to $6.50 and gave the stock an “equal weight” rating in a research note on Wednesday, May 6th. Wells Fargo & Company lifted their price target on shares of American Well from $9.00 to $16.00 and gave the company an “overweight” rating in a report on Friday, July 17th. Weiss Ratings reissued a “sell (d-)” rating on shares of American Well in a research report on Friday, July 17th. Finally, Truist Financial set a $7.50 price objective on shares of American Well in a report on Monday, June 8th. One investment analyst has rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $8.60.

About American Well

American Well, operating under the trade name Amwell, is a Boston-based digital health company that develops and delivers telehealth solutions to healthcare providers, payers, employers and patients. Through its cloud-based platform, the company enables secure virtual visits, remote patient monitoring and integrated care coordination across a range of medical disciplines, including primary care, behavioral health, chronic disease management and urgent care.

The company’s core offering, the Amwell Telehealth Platform, facilitates live video consultations, asynchronous messaging, e-prescribing and electronic health record integration.